Skip to main content

Date last updated: 01/25/2022

 

General comments:  We provide these summary data in the spirit of transparency and open data sharing.  Given the relatively small number of reported cases and preliminary nature of these reports, we do not recommend these data be used to inform clinical decisions at this time. Additionally, as many mild cases of COVID-19 do not undergo testing, these data may over-represent more severe cases in which COVID-19 testing was performed. Please note that rows and columns from tables below may not add up to the exact number of total reported cases due to incomplete data and/or non-mutually exclusive variables.

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.

 

Total number of cases reported: 7,038

 

Report a Case

Cases reported by country*

countryN
United States2423
United Arab Emirates27
Afghanistan1
Argentina97
Austria138
Australia47
Belgium178
Bulgaria43
Bahrain1
Saint Barthélemy1
Bolivia, Plurinational State of1
Brazil146
Canada236
Switzerland44
Chile43
China1
Colombia3
Costa Rica4
Cyprus4
Czech Republic60
Germany233
Denmark1
Dominican Republic16
Ecuador5
Egypt3
Spain516
Finland7
France131
United Kingdom239
Greece107
Croatia26
Hungary6
Ireland100
Israel46
India39
Iran, Islamic Republic of59
Italy188
Jamaica1
Japan90
Korea, Republic of5
Kuwait24
Kazakhstan1
Lebanon3
Luxembourg1
Latvia10
Morocco8
Moldova, Republic of14
Mexico33
Malaysia3
Netherlands406
Norway22
Nepal1
New Zealand1
Peru10
Philippines6
Poland54
Portugal138
Paraguay1
Qatar2
Romania16
Serbia15
Russian Federation557
Saudi Arabia14
Sweden2
Singapore1
Slovenia16
Slovakia113
Tunisia2
Turkey128
Ukraine4
Uruguay9
Venezuela, Bolivarian Republic of4
South Africa17
Missing86

* Countries not included in this table have not reported any cases to SECURE-IBD

 

Cases reported by state (U.S. only)*

stateN
ALABAMA24
ARIZONA20
ARKANSAS14
CALIFORNIA135
COLORADO17
CONNECTICUT33
DELAWARE4
DISTRICT OF COLUMBIA10
FLORIDA126
GEORGIA69
IDAHO9
ILLINOIS201
INDIANA14
IOWA23
KANSAS15
KENTUCKY14
LOUISIANA45
MAINE2
MARYLAND55
MASSACHUSETTS72
MICHIGAN54
MINNESOTA81
MISSISSIPPI29
MISSOURI46
MONTANA12
NEBRASKA47
NEVADA6
NEW HAMPSHIRE4
NEW JERSEY91
NEW MEXICO1
NEW YORK303
NORTH CAROLINA96
NORTH DAKOTA3
OHIO150
OKLAHOMA16
OREGON12
PENNSYLVANIA99
RHODE ISLAND26
SOUTH CAROLINA23
SOUTH DAKOTA3
TENNESSEE62
TEXAS93
UTAH19
VERMONT5
VIRGINIA51
WASHINGTON38
WEST VIRGINIA2
WISCONSIN64
GUAM2
PUERTO RICO7
NA76

* States not included in this table have not reported any cases to SECURE-IBD

 

Cases and outcomes by patient characteristics

CharacteristicTotal NOutpatient only (n, %)Hospitalized (n, %)ICU (n, %)Ventilator (n, %)Death (n, %)ICU/Ventilator/Death (n, %)
Overall7,0385,92384%1,01314%1923%1482%1072%2684%
Age
0-9 years 464189%37%24%24%00%24%
10-19 years 76472094%355%61%20%00%61%
20-29 years 1,4511,33192%1037%40%10%10%50%
30-39 years 1,4731,31389%1349%161%81%40%171%
40-49 years 1,2721,09386%16613%262%181%40%292%
50-59 years 1,05182178%21821%444%414%141%616%
60-69 years 56737165%18332%5810%488%305%6912%
70-79 years 23312755%10043%2712%209%2410%4218%
>=80 years 1427150%6747%75%86%2920%3525%
Sex
Male 3,3772,76582%56817%1063%822%742%1555%
Female 3,5363,05186%43212%832%632%331%1103%
Other 3267%00%00%00%00%00%
Disease type
Crohn’s disease 4,0193,48387%48212%822%682%481%1153%
Ulcerative Colitis/unspecified2,9702,40181%52518%1084%783%582%1515%
IBD Disease
Activity
Remission3,8983,37487%49113%972%802%521%1384%
Mild1,4701,26486%18613%302%221%201%453%
Moderate/Severe1,30299176%28922%554%383%292%736%
Unknown36829480%4713%103%82%62%123%
Smoking
Current smoker28824384%4516%62%21%52%93%
Non-smoker6,7505,68084%96814%1863%1462%1022%2594%
Comorbidities
05,0464,53090%4519%561%401%100%691%
11,3841,07578%28220%544%413%312%725%
237823161%14137%359%339%246%5314%
3+2308738%13960%4720%3415%4218%7432%
IBD medication
Sulfasalazine/mesalamine2,0881,64579%42220%824%703%533%1196%
Budesonide 18814477%4222%95%53%63%126%
Oral/parenteral steroids 43927763%15335%4210%307%286%5412%
6MP/azathioprine monotherapy59447279%11820%285%183%112%356%
Methotrexate monotherapy564071%1425%12%12%35%47%
Anti-TNF without 6MP/AZA/MTX 2,3072,09191%1888%261%191%110%341%
Anti-TNF + 6MP/AZA/MTX 70860285%9313%172%122%61%213%
Anti-integrin 75664385%9713%223%111%91%294%
IL 12/23 inhibitor 65859190%548%102%91%51%122%
JAK inhibitor 12110486%1311%43%11%11%43%
Other IBD medication 22517678%4520%104%63%52%104%

*Medication categories are not mutually exclusive

 

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.